This webpage contains legacy information. The product is either no longer available from the supplier or has been delisted at Labome.
product summary
company name :
Alomone Labs
product type :
antibody
product name :
Guinea pig Anti-proNGF Antibody
catalog :
AGP-031
quantity :
25 µl, 50 µl, 0.2 ml
clonality :
polyclonal
host :
guinea-pigs
conjugate :
nonconjugated
reactivity :
human, mouse, rat
application :
western blot, immunohistochemistry, immunocytochemistry
citations: 1
product information
Vendor :
Alomone Labs Ltd.
Item Name :
Guinea pig Anti-proNGF Antibody
Catalog Number :
AGP-031
Product type :
Antibody
Size :
25 µl, 50 µl, 0.2 ml
Homology :
Mouse - identical; human - 16/21 amino acid residues identical.
Synonyms :
proNGF, Nerve growth factor precursor
crossreactivity :
Human, Mouse, Rat
Applications :
Immunofluorescence, Immunohistochemistry, Western Blot
Antibody Type :
Polyclonal
Host :
Guinea pig
Conjugate/Tag/Label :
Unconjugated
SwissProtID :
P25427
Concentration :
0.8 mg/ml
Format :
Lyophilized powder. Reconstituted antibody contains phosphate buffered saline (PBS), pH 7.4, 1% BSA, 0.05% NaN3.
Buffer :
Phosphate buffered saline (PBS), pH 7.4
Preservative :
1% BSA, 0.05% NaN3
Packaging :
Lyophilized powder
Storage :
The antibody ships as a lyophilized powder at room temperature. Upon arrival, it should be stored at -20°C.
Purity :
Affinity purified on immobilized antigen.
Isotype :
Guinea pig total IgG
Immunogen :
Synthetic peptide
Clonality :
Polyclonal
Domain/Region/Terminus :
Pro-domain of the NGF protein
Immunogen Sequence :
(C)SPRVLFSTQPPPTSSDTLDLD, corresponding to amino acid residues 84-104 of rat NGF (precursor)
Category :
Neurotrophins, Neurotrophic Factors, proneurotrophins, pre-neurotrophins
Research Area(s) :
Breast cancer, Cancer, Neurodegenerative diseases, Alzheimer's disease, Neuroscience
company information

Alomone Labs
Jerusalem BioPark (JBP), Hadassah Ein Kerem
P.O. Box 4287
Jerusalem 9104201
P.O. Box 4287
Jerusalem 9104201
info@alomone.com
http://www.alomone.com972 2 531 8002
headquarters: Israel
questions and comments